Drugs / 2-phenylethanol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07116421 | Jul 2025 → May 2027 expected | epilepsy | Vanderbilt University Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2-phenylethanol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07116421 ↗ |
| Route | Other | “Route of administration: Essential oil diffuser” NCT07116421 ↗ |